光莆股份(300632.SZ):擬使用額度不超8億元閒置自有資金購買短期理財產品
格隆匯 3 月 1日丨光莆股份(300632.SZ)公佈,2021年2月28日,公司召開了第三屆董事會第二十六次會議及第三屆監事會第二十一次會議,審議通過了《關於使用閒置自有資金購買理財產品的議案》,為最大限度地發揮階段性閒置自有資金的作用,進一步提高閒置資金使用效率,為公司股東謀取更多的投資回報,在確保公司正常經營資金需求和有效控制風險的前提下,公司及子公司擬使用額度不超過人民幣8億元的閒置自有資金購買安全性高、流動性好、發行主體優質的短期理財產品。在該額度範圍內,資金可以滾動使用,但任一時點持有未到期的理財產品總額不超過人民幣8億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.